GEA
IBD icon

Glen Eagle Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Glen Eagle Advisors’s Portfolio IBD Stock Details IBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-386
Closed -$9.18K – 1074
2025
Q1 		$9.18K Buy
386
+2
+0.5% +$47 ﹤0.01% 653
2024
Q4 		$9.01K Buy
384
+6
+2% +$142 ﹤0.01% 671
2024
Q3 		$9.11K Buy
378
+4
+1% +$95 ﹤0.01% 673
2024
Q2 		$8.73K Buy
374
+3
+0.8% +$70 ﹤0.01% 674
2024
Q1 		$8.7K Buy
371
+304
+454% +$7.15K ﹤0.01% 681
2023
Q4 		$1.58K Buy
67
+1
+2% +$23 ﹤0.01% 890
2023
Q3 		$1.49K Hold
66
– – ﹤0.01% 895
2023
Q2 		$1.51K Buy
66
+1
+2% +$23 ﹤0.01% 903
2023
Q1 		$1.52K Hold
65
– – ﹤0.01% 898
2022
Q4 		$1.49K Buy
65
+1
+2% +$23 ﹤0.01% 947
2022
Q3 		$1.45K Hold
64
– – ﹤0.01% 924
2022
Q2 		$1.49K Buy
64
+18
+39% +$427 ﹤0.01% 863
2022
Q1 		$1.11K Hold
46
– – ﹤0.01% 866
2021
Q4 		$1.17K Buy
46
+1
+2% +$26 ﹤0.01% 856
2021
Q3 		$1.18K Hold
45
– – ﹤0.01% 979
2021
Q2 		$1.19K Hold
45
– – ﹤0.01% 963
2021
Q1 		$1.17K Buy
+45
New +$1.18K ﹤0.01% 930

Other funds holding IBD

IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
FA
Faithward Advisors Lancaster, Pennsylvania $701M AUM 32.17% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $378M AUM 15.71% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return
CIA
Christian Investment Advisors New Braunfels, Texas $158M AUM 11.26% 1-Year Est. Return
PFG
PAX Financial Group San Antonio, Texas $586M AUM 15.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $302M AUM 15.12% 1-Year Est. Return

Glen Eagle Advisors's IBD Position: Q2 2025 in Review

Glen Eagle Advisors sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 386 shares — an estimated $9.18K sold.

Glen Eagle Advisors first reported a position in IBD in Q1 2021 and held it in 17 quarters. The position peaked at $9.18K in Q1 2025. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • Glen Eagle Advisors reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 386 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $9.18K.
  • Glen Eagle Advisors first reported a position in Inspire Corporate Bond ETF in Q1 2021 and held it in 17 quarters.
  • Glen Eagle Advisors's Inspire Corporate Bond ETF position peaked at $9.18K in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on Glen Eagle Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.